HIV-1 Tat increases cell survival in response to cisplatin by stimulating Rad51 gene expression

Oncogene

Volumn 23, Issue 15, 2004, Pages 2664-2671

  Chipitsyna, Galina ^a   Slonina, Dorota ^a   Siddiqui, Khwaja ^a   Peruzzi, Francesca ^a   Skorski, Tomasz ^a   Reiss, Krzysztof ^a   Sawaya, Bassel E ^a   Khalili, Kamel ^a   Amini, Shohreh ^a  

^a Temple University   (United States)

Author keywords

DNA repair; HIV 1 tat

Indexed keywords

CISPLATIN; DOUBLE STRANDED DNA; RAD51 PROTEIN; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; CELL ACTIVITY; CELL STIMULATION; CELL STRAIN; CELL SURVIVAL; CHROMOSOME BREAKAGE; COMET ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DAMAGE; DNA REPAIR; FLUORESCENCE; GENE; GENE EXPRESSION; GENOTOXICITY; HOMOLOGOUS RECOMBINATION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAD51 GENE; RAT; SEQUENCE HOMOLOGY; SURVIVAL RATE;

ANIMALS; ANTIGENS, NUCLEAR; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL SURVIVAL; CHROMOSOME ABERRATIONS; CISPLATIN; COMET ASSAY; DNA DAMAGE; DNA REPAIR; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; GENE PRODUCTS, TAT; GENES, REPORTER; LUCIFERASES; PC12 CELLS; PLASMIDS; RAD51 RECOMBINASE; RATS; TIME FACTORS; TRANS-ACTIVATION (GENETICS);

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 2342643465     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207417     Document Type: Article

References (38)

1. Aguilera A. (2001). Trends Genet., 17, 318-321.
2. Barboric M, Nissen RM, Kanazawa S, Jabrane-Ferrat N and Peterlin BM. (2001). Mol. Cell, 8, 327-337.
3. Baumann P and West SC. (1998). Proc. Natl. Acad. Sci. USA, 24, 14066-14070.
4. Bennasser Y, Badou A, Tkaczuk J and Bahraoui E. (2002). Virology, 303, 174-180.
5. Berkhout B, Verhoef K, Marzio G, Klaver B, Vink M, Zhou X and Das AT. (2002). J. Neurovirol., 8 (Suppl 2), 134-137.
6. Brown KD, Rathi A, Kamath R, Beardsley DI, Zhan Q, Mannino JL and Baskaran R. (2003). Nat. Genet., 33, 80-84.
7. Buonaguro L, Barillari G, Chang HK, Bohan CA, Kao V, Morgan R, Gallo RC and Ensoli B. (1992). J. Virol., 66, 7159-7167.
8. Chen P, Mayne M, Power C and Nath A. (1997). J. Biol. Chem., 272, 22385-22388.
9. Clark E, Santiago F, Deng L, Chong S, de La Fuente C, Wang L, Fu P, Stein D, Denny T, Lanka V, Mozafari F, Okamoto T and Kashanchi F. (2000). J. Virol., 74, 5040-5052.
10. Douek DC, Picker LJ and Koup RA. (2003). Ann. Rev. Immunol., 21, 265-304.
11. Duan L, Ozaki I, Oakes JW, Taylor JP, Khalili K and Pomerantz RJ. (1994). J. Virol., 68, 4302-4313.
12. Esposito G, Ligresti A, Izzo AA, Bisogno T, Ruvo M, Di Rosa M, Di Marzo V and Iuvone T. (2002). J. Biol. Chem., 277, 50348-50354.
13. Featherstone C and Jackson SP. (1999). Mutat. Res., 434, 3-15.
14. Gonzalez E, Punzon C, Gonzalez M and Fresno M. (2001). J. Immunol., 166, 4560-4569.
15. Green MH, Lowe JE, Waugh AP, Aldridge KE, Cole J and Arlett CF. (1994). Mutant Res., 316, 91-102.
16. Kai M and Wang TS. (2003). Genes Dev., 17, 64-76.
17. Kashanchi F, Agbottah ET, Pise-Masison CA, Mahieux R, Duvall J, Kumar A and Brady JN. (2000). J. Virol., 74, 652-660.
18. Kundu M, Sharma S, De Luca A, Giordano A, Rappaport J, Khalili K and Amini S. (1998). J. Biol. Chem., 273, 8130-8136.
19. Lambotte O, Deiva K and Tardieu M. (2003). Brain Pathol., 13, 95-103.
20. Lee SH and Kim CH. (2002). Mol. Cell, 13, 159-166.
21. Li CJ, Wang C, Friedman DJ and Pardee A. (1995). Proc. Natl. Acad. Sci. USA, 92, 5461-5464.
22. Liang C and Wainberg MA. (2002). AIDS Rev., 4, 41-49.
23. Magnusson KP, Sandstrom M, Stahlberg M, Larsson M, Flygare J, Hellgren D, Wiman KG and Ljungquist S. (2000). Gene, 246, 247-254.
24. Mahieux R, Lambert PF, Agbottah E, Halanski MA, Deng L, Kashanchi F and Brady JN. (2001). J. Virol., 75, 1736-1743.
25. McCloskey TW, Ott M, Tribble E, Khan SA, Teichberg S, Paul MO, Pahwa S, Verdin E and Chirmule N. (1997). J. Immunol., 158, 1014-1019.
26. Persaud D, Zhou Y, Siliciano JM and Siliciano RF. (2003). J. Virol., 77, 1659-1665.
27. Peruzzi F, Gordon J, Darbinian N and Amini S. (2002). J. Neurovirol., 8 (Suppl 2), 91-96.
28. Phimister EG. (2003). N. Engl. J. Med., 348, 643-644.
29. Pierce AJ, Johnson RD, Thompson LH and Jasin M. (1999). Genes Dev., 15, 2633-2638.
30. Rappaport J, Joseph J, Croul S, Alexander G, Del Valle L, Amini S and Khalili K. (1999). J. Leukoc. Biol., 65, 458-465.
31. Rautonen N, Rautonen J, Martin NL and Wara DW. (1994). AIDS, 8, 1504-1506.
32. Reynolds L, Ullman C, Moore M, Isalan M, West MJ, Clapham P, Klug A and Choo Y. (2003). Proc. Natl. Acad. Sci. USA, 100, 1615-1620.
33. Sawaya BE, Khalili K, Gordon J, Taube R and Amini S. (2000). J. Biol. Chem., 275, 35209-35214.
34. Sawaya BE, Thatikunta P, Denisova L, Brady J, Khalili K and Amini S. (1998). J. Neuroimmunol., 87, 33-42.
35. Sengupta S, Linke SP, Pedeux R, Yang Q, Farnsworth J, Garfield SH, Valerie K, Shay JW, Ellis NA, Wasylyk B and Harris CC. (2003). EMBO J., 22, 1210-1222.
36. Shi B, Raina J, Lorenzo A, Busciglio J and Gabuzda D. (1998). J. Neurovirol., 4, 281-290.
37. Singh NP, Stephens RE and Schneider EL. (1994). Int. J. Radiat. Biol., 66, 23-28.
38. Venkitaraman AR. (2002). Cell, 108, 171-182.